Exciting Clinical Trials for CLL in 2025 image

Exciting Clinical Trials for CLL in 2025

Sep 02, 2025
03:00PM - 04:00PM EDT
Online Event
Overview

Join the HealthTree Foundation for this webinar with a CLL specialist where we will be discussing what clinical trials the experts are most excited about. This is a great opportunity to learn about ongoing clinical trials and ask questions to a CLL specialist about clinical trials.

 

 

 

Agenda
3:00 PM
Introduction
Dalton Bean

Dalton introduces the agenda of the event and featured speaker Ryan W Jacobs, MD

3:05 PM
Presentation
Ryan Jacobs, MD

Dr. Jacobs talks about clinical trials for CLL patients

3:35 PM
Questions and Answers
Dalton Bean

Type your questions in the chat, we will answer them!

Speakers & Moderators
Healthtree contact Dalton Bean

Dalton Bean

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Healthtree contact Ryan Jacobs, MD

Ryan Jacobs, MD

“I have always been interested in the science and treatment of cancer.” Dr. Jacobs is board certified in hematology-oncology (cancer and blood disorders). He has clinical interests in lymphoma and chronic lymphocytic leukemia (CLL). He is an associate professor of medicine and Director of the Lymphoma Division at Atrium Health’s Levine Cancer Institute. Dr. Jacobs received his bachelor’s degree at Texas Tech and his medical degree at Baylor College of Medicine. He completed residency at Vanderbilt University and a fellowship at the University of Texas MD Anderson Cancer Center. Outside of work, he loves spending time with his wife and 2 children. He enjoys hiking, watching movies and reading literature.